4-119150976-C-A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_016599.5(MYOZ2):c.181C>A(p.Arg61Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R61H) has been classified as Uncertain significance.
Frequency
Consequence
NM_016599.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 16Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYOZ2 | NM_016599.5 | c.181C>A | p.Arg61Ser | missense_variant | Exon 3 of 6 | ENST00000307128.6 | NP_057683.1 | |
| MYOZ2 | NM_001440645.1 | c.181C>A | p.Arg61Ser | missense_variant | Exon 3 of 7 | NP_001427574.1 | ||
| MYOZ2 | NM_001440646.1 | c.181C>A | p.Arg61Ser | missense_variant | Exon 3 of 6 | NP_001427575.1 | ||
| LOC105379404 | XR_001741421.2 | n.-17G>T | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at